These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 2266473)

  • 21. Targeting of liposome-associated calcipotriol to the skin: effect of liposomal membrane fluidity and skin barrier integrity.
    Knudsen NØ; Jorgensen L; Hansen J; Vermehren C; Frokjaer S; Foged C
    Int J Pharm; 2011 Sep; 416(2):478-85. PubMed ID: 21419203
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Factors affecting microencapsulation of drugs in liposomes.
    Kulkarni SB; Betageri GV; Singh M
    J Microencapsul; 1995; 12(3):229-46. PubMed ID: 7650588
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Improvement of iron removal from the reticuloendothelial system by liposome encapsulation of N,N'-bis[2-hydroxybenzyl]-ethylenediamine-N,N'-diacetic acid (HBED). Comparison with desferrioxamine.
    Lau EH; Cerny EA; Wright BJ; Rahman YE
    J Lab Clin Med; 1983 May; 101(5):806-16. PubMed ID: 6403640
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Enhancement of topical delivery of a lipophilic drug from charged multilamellar liposomes.
    Katahira N; Murakami T; Kugai S; Yata N; Takano M
    J Drug Target; 1999; 6(6):405-14. PubMed ID: 10937286
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A fibrin encapsulated liposomes-in-chitosan matrix (FLCM) for delivering water-soluble drugs. Influences of the surface properties of liposomes and the crosslinked fibrin network.
    Chung TW; Yang MC; Tsai WJ
    Int J Pharm; 2006 Mar; 311(1-2):122-9. PubMed ID: 16446064
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effect of liposomal incorporation of topically applied hydrocortisone on its serum concentration and urinary excretion.
    Wohlrab W; Lasch J
    Dermatol Monatsschr; 1989; 175(6):348-52. PubMed ID: 2759315
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Cutaneous administration of liposomes--a review of the literature with special reference to findings from keratinocyte cultures, animal experiments and clinical studies].
    Bonnekoh B; Mahrle G
    Z Hautkr; 1990 Jan; 65(1):99-105. PubMed ID: 2183509
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Imaging liposomes at electron microscopic level: encapsulated colloidal iron as an electrondense marker for liposome-cell interactions.
    Foldvari M; Faulkner GT; Mezei M
    J Microencapsul; 1988; 5(3):231-41. PubMed ID: 3199308
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pilocarpine hydrochloride liposomes: characterization in vitro and preliminary evaluation in vivo in rabbit eye.
    Benita S; Plenecassagne JD; Cavé G; Drouin D; Le Hao Dong P; Sincholle D
    J Microencapsul; 1984; 1(3):203-16. PubMed ID: 6336525
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Liposomes: a drug carrier system for topical treatment in dermatology.
    Schmid MH; Korting HC
    Crit Rev Ther Drug Carrier Syst; 1994; 11(2-3):97-118. PubMed ID: 7600589
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Facilitated skin penetration of lidocaine: combination of a short-term iontophoresis and microemulsion formulation.
    Sintov AC; Brandys-Sitton R
    Int J Pharm; 2006 Jun; 316(1-2):58-67. PubMed ID: 16564144
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sustained release of liposome-encapsulated enrofloxacin after intramuscular administration in rabbits.
    Cabanes A; Reig F; Antón JM; Arboix M
    Am J Vet Res; 1995 Nov; 56(11):1498-501. PubMed ID: 8585663
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Liposomes and skin: from drug delivery to model membranes.
    El Maghraby GM; Barry BW; Williams AC
    Eur J Pharm Sci; 2008 Aug; 34(4-5):203-22. PubMed ID: 18572392
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development of SLNs from natural lipids: application to topical delivery of tretinoin.
    Mandawgade SD; Patravale VB
    Int J Pharm; 2008 Nov; 363(1-2):132-8. PubMed ID: 18657601
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dermal and transdermal delivery of an anti-psoriatic agent via ethanolic liposomes.
    Dubey V; Mishra D; Dutta T; Nahar M; Saraf DK; Jain NK
    J Control Release; 2007 Nov; 123(2):148-54. PubMed ID: 17884226
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interaction of cultured human keratinocytes with liposomes encapsulating silver sulphadiazine: proof of the uptake of intact vesicles.
    Schaller M; Korting HC; Schmid MH
    Br J Dermatol; 1996 Mar; 134(3):445-50. PubMed ID: 8731667
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Preparation of long-circulating nolatrexed dihydrochloride liposomes and its antitumor activity].
    Chen SZ; Wang SM; Zhang JR
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 Mar; 28(3):403-5. PubMed ID: 18359701
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Current progress and future prospects of liposomes in dermal drug delivery.
    Moghimi SM; Patel HM
    J Microencapsul; 1993; 10(2):155-62. PubMed ID: 8331490
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Can drug-bearing liposomes penetrate intact skin?
    El Maghraby GM; Williams AC; Barry BW
    J Pharm Pharmacol; 2006 Apr; 58(4):415-29. PubMed ID: 16597359
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Liposomes in cosmeceutics.
    Rahimpour Y; Hamishehkar H
    Expert Opin Drug Deliv; 2012 Apr; 9(4):443-55. PubMed ID: 22413847
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.